Revenue
2021
2022
2023
2024
2025
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue | — | €167.9M | €167.7M | €156.0M | €155.9M | €177.8M |
| Research & development | — | €381,000 | €294,000 | €437,000 | €375,000 | — |
| Operating expenses | — | €110.4M | €100.0M | €78.5M | €63.4M | — |
| Operating income | — | €1.1M | €20.9M | €17.3M | €13.3M | €27.5M |
| Operating margin | — | 0.66% | 12.45% | 11.11% | 8.56% | 15.45% |
| EBITDA | — | €59.6M | €70.9M | €48.9M | €39.0M | €55.2M |
| EBITDA margin | — | 35.52% | 42.28% | 31.36% | 25.00% | 31.07% |
| Net income | — | −€1.3M | €17.5M | €12.8M | €10.0M | €18.2M |
| Net profit margin | — | −0.80% | 10.45% | 8.19% | 6.40% | 10.26% |
| Basic EPSper basic share | -€3.36 | -€0.01 | €0.20 | €0.15 | €0.12 | €0.22 |
| Diluted EPSper diluted share | -€3.36 | -€0.01 | €0.19 | €0.14 | €0.12 | €0.21 |